For oral cancer in animal models, anti-NGF mAbs impair the proper activation of NGF, decrease the volume of tumour lesions and relieve weight loss, accompanied by decreased levels of nociceptive receptors (Ye et al. 2011). The gene discussed is NGF; the disease is neoplasm.